Literature DB >> 11807954

Modulation of cyclophilin gene expression by N-4-(hydroxyphenyl)retinamide: association with reactive oxygen species generation and apoptosis.

Stephen D Hursting1, Jian-cheng Shen, Xiao-Ya Sun, Thomas T Y Wang, James M Phang, Susan N Perkins.   

Abstract

To explore the mechanisms underlying the pro-apoptotic effects of the synthetic retinoid N-4-(hydroxyphenyl)retinamide (4-HPR) on LNCaP human prostate cancer cells, we used the differential display-polymerase chain reaction (DD-PCR) technique to identify 4-HPR-responsive genes. RNA extracted from LNCaP cells that had been treated for 24 h with 4-HPR at a dose (2.5 microM) optimal for apoptosis induction was used for DD-PCR analysis using random primers. A differentially expressed 115 bp fragment was cloned and sequenced and then identified in GenBank as having a high degree of homology with several members of the cyclophilin gene family. Northern blot analyses using specific probes for cyclophilin A, cyclophilin D, and the cloned 115-bp fragment were performed on RNA extracted from LNCaP cells and MCF-7 human breast cancer cells treated with 4-HPR, N-acetylcysteine (NAC, an anti-oxidant), 4-HPR plus NAC, cyclosporin A, R-1881 (a synthetic androgen), dehydroepiandrosterone, all-trans retinoic acid, or prednisone. 4-HPR downregulated the transcript detected by the 115-bp fragment. Expression patterns detected by the 115-bp fragment and cyclophilin D probes were identical in response to each treatment; none of these treatments affected cyclophilin A expression. Furthermore, expression of mRNA transcripts detected by the 115-bp fragment and cyclophilin D probes correlated with the generation of reactive oxygen species (ROS), as detected by measurement of 2,7-dichlorofluorescein oxidation. Therefore, members of the cyclophilin gene family, such as cyclophilin D (a component of the mitochondrial permeability transition pore previously linked with oxidative stress and apoptosis), may play a role in the ROS-mediated apoptotic effects of 4-HPR. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807954     DOI: 10.1002/mc.10020

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.

Authors:  Numsen Hail; Ping Chen; Michael F Wempe
Journal:  Free Radic Biol Med       Date:  2010-10-23       Impact factor: 7.376

2.  Selective apoptosis induction by the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide is achieved by modulating mitochondrial bioenergetics in premalignant and malignant human prostate epithelial cells.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa
Journal:  Apoptosis       Date:  2009-07       Impact factor: 4.677

3.  Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.

Authors:  Numsen Hail; Ping Chen; Jadwiga J Kepa; Lane R Bushman; Colin Shearn
Journal:  Free Radic Biol Med       Date:  2010-04-24       Impact factor: 7.376

Review 4.  Roles of cyclophilins in cancers and other organ systems.

Authors:  Qizhi Yao; Min Li; Hui Yang; Hong Chai; William Fisher; Changyi Chen
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

5.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

6.  N-(4-Hydroxyphenyl)retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species.

Authors:  Hiroaki Goto; Hiroyuki Takahashi; Hisaki Fujii; Koichiro Ikuta; Shumpei Yokota
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

7.  Retinoid Expression in Onchocercal Skin Disease: Pilot Study.

Authors:  Anthony R Mawson; Williams H Makunde; Alan D Penman; Veronica de Los Angeles Hernandez Morales; Akili K Kalinga; Filbert Francis; Semyon Rubinchik; Addow Kibweja
Journal:  Infect Dis (Auckl)       Date:  2017-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.